Ruxolitinib for treating moderate to severe chronic graft versus host disease after an allogeneic stem cell transplant in people 28 days to 17 years (terminated appraisal) TA1132 17 February 2026 17 ...
This project builds a Retrieval-Augmented Generation (RAG) learning assistant that enables students to upload academic documents (PDFs, DOCX, etc.) and receive AI-powered, context-aware answers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results